Startups
Edit
GreenLight Biosciences, Inc.
http://www.greenlightbio.com/Last activity: 01.08.2022
Active - Reference to GreenLight Biosciences
Overview
Location
United States, Massachusetts, Medford
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 24, 2021 | GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing | BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, an... |
| Sep 23, 2021 | GreenLight Biosciences : opens RNA production facility for the next generation of agricultural products | ROCHESTER, N.Y., Sept. 22, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, announced the opening of its manufacturing plant i... |
| Mar 9, 2021 | Feasibility Arrangement for Shelf-stable Powder Form of Messenger RNA COVID-19 Vaccine Candidate Announced by GreenLight Biosciences and TFF Pharmaceuticals | MEDFORD, Mass. & AUSTIN, Texas--(BUSINESS WIRE)--Mar 9, 2021-- GreenLight Biosciences, Inc., a privately-held RNA vaccine developer and manufacturer, and TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical compa... |
| Sep 14, 2017 | GreenLight Biosciences Closes $18M Series D Financing | GreenLight Biosciences, Inc., a Medford, Mass.-based developer of a platform to develop a portfolio of RNA-based products for use in agriculture, completed a $18m Series D round of financing. The round was led by Fall Line Capital, with par... |
| Sep 13, 2017 | GreenLight Biosciences Announces $18M Series D Financing | GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with... |
Reviews 0
FAQ about GreenLight Biosciences, Inc.
What has the press written about GreenLight Biosciences, Inc.?
Parsers VC has collected 6 articles mentioning GreenLight Biosciences, Inc., among them “GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing” (Nov 24, 2021) and “GreenLight Biosciences : opens RNA production facility for the next generation of agricultural products” (Sep 23, 2021).
Is GreenLight Biosciences, Inc. still active?
Yes, GreenLight Biosciences, Inc. is active; its latest activity on Parsers VC dates from Aug 1, 2022.